ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Featuring perspectives from Dr Virginia F Borges and Dr Ian E Krop, including the following topics:

Introduction: Biology of "Triple-Positive" Breast Cancer; Implications for Therapeutic Development (0:00)

Cases from the GMO Survey (13:01)

First-Line Therapy for Metastatic HER2-Positive Disease (20:01)

Maintenance Therapy for HR-Positive, HER2-Positive Disease (30:03)

Maintenance Therapy for HR-Negative, HER2-Positive Disease (46:30)

Cases from the GMO Survey (50:00)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.